Skip to main content
Immunology logoLink to Immunology
. 1995 Nov;86(3):463–468.

Up-regulation of cytokine mRNA in human monocytes and myeloid cell lines by the differentiation/activation factor p48.

D P Kestler 1, S Agarwal 1, R E Hall 1
PMCID: PMC1383952  PMID: 8550086

Abstract

Polypeptide 48 is a 48,000 MW protein, originally isolated from conditioned media of some human leukaemic cell lines, that induces differentiation and cytolytic activity in HL-60 promyelocytic leukaemia cells and activates human peripheral blood monocytes to secrete interleukin-1 (IL-1) and tumour necrosis factor-alpha (TNF-alpha). In the present study we examined the effects of p48 on the accumulation of a series of monokine transcripts, including TNF-alpha, IL-1 alpha, IL-1 beta and IL-6, in human peripheral blood monocytes and the myeloid/monocyte cell lines HL-60 and U937. Using reverse transcriptase polymerase chain reaction (RT-PCR) and Northern blot analysis, p48 was found to induce accumulation of TNF-alpha, IL-1 alpha and IL-1 beta mRNA in peripheral blood monocytes, HL-60 and U937 cells. IL-6 mRNA was found to be increased in p48-stimulated peripheral blood monocytes but not HL-60 or U937. Thus, the secretion of IL-1 and TNF-alpha by p48-stimulated monocytic cells was associated with up-regulation of cytokine mRNA, suggesting that p48 leads to increased transcription or mRNA stability in these cells. As U937 and HL-60 are likely to represent premonocyte stages of haemopoietic differentiation, it is possible that the effect of p48 on IL-6 mRNA, in contrast to its effect on TNF and IL-1, requires cells to be at a later differentiation step.

Full text

PDF
464

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi: 10.1016/s0065-2776(08)60532-5. [DOI] [PubMed] [Google Scholar]
  2. Bachwich P. R., Chensue S. W., Larrick J. W., Kunkel S. L. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem Biophys Res Commun. 1986 Apr 14;136(1):94–101. doi: 10.1016/0006-291x(86)90881-8. [DOI] [PubMed] [Google Scholar]
  3. Beezhold D. H., Leftwich J. A., Hall R. E. P48 induces tumor necrosis factor and IL-1 secretion by human monocytes. J Immunol. 1989 Nov 15;143(10):3217–3221. [PubMed] [Google Scholar]
  4. Bogdan C., Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci. 1993 Jun 23;685:713–739. doi: 10.1111/j.1749-6632.1993.tb35934.x. [DOI] [PubMed] [Google Scholar]
  5. Brenner C. A., Tam A. W., Nelson P. A., Engleman E. G., Suzuki N., Fry K. E., Larrick J. W. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 1989 Nov-Dec;7(10):1096–1103. [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Collart M. A., Belin D., Vassalli J. D., de Kossodo S., Vassalli P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med. 1986 Dec 1;164(6):2113–2118. doi: 10.1084/jem.164.6.2113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Descoteaux A., Matlashewski G. Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor. J Immunol. 1990 Aug 1;145(3):846–853. [PubMed] [Google Scholar]
  9. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  10. Farrar M. A., Schreiber R. D. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol. 1993;11:571–611. doi: 10.1146/annurev.iy.11.040193.003035. [DOI] [PubMed] [Google Scholar]
  11. Gruber M. F., Gerrard T. L. Production of macrophage colony-stimulating factor (M-CSF) by human monocytes is differentially regulated by GM-CSF, TNF alpha, and IFN-gamma. Cell Immunol. 1992 Jul;142(2):361–369. doi: 10.1016/0008-8749(92)90297-3. [DOI] [PubMed] [Google Scholar]
  12. Gullberg U., Nilsson E. Recombinant lymphotoxin enhances the growth of normal, but not of chronic myeloid leukemic, human hematopoietic progenitor cells in vitro. Leuk Res. 1989;13(11):953–957. doi: 10.1016/0145-2126(89)90001-5. [DOI] [PubMed] [Google Scholar]
  13. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol. 1985 Apr;37(4):407–422. doi: 10.1002/jlb.37.4.407. [DOI] [PubMed] [Google Scholar]
  14. Horii Y., Muraguchi A., Suematsu S., Matsuda T., Yoshizaki K., Hirano T., Kishimoto T. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol. 1988 Sep 1;141(5):1529–1535. [PubMed] [Google Scholar]
  15. Kostyal D. A., Beezhold D. H., Hall R. E. Differentiation-inducing cytokine P48 exists in a membrane-associated form. J Immunol. 1991 Aug 1;147(3):893–898. [PubMed] [Google Scholar]
  16. Kramnik I., Skamene E., Radzioch D. Assessment of lymphokine profiles in activated lymphocytes by semiquantitative PCR. J Immunol Methods. 1993 Jun 18;162(2):143–153. doi: 10.1016/0022-1759(93)90379-l. [DOI] [PubMed] [Google Scholar]
  17. Leftwich J. A., Hall R. E. Initial characterization of a cytokine which induces differentiation and cytolytic activity in HL-60 promyelocytic leukemia cells: evidence that the cytokine is distinct from other known differentiation-active cytokines. J Leukoc Biol. 1990 Jan;47(1):87–96. doi: 10.1002/jlb.47.1.87. [DOI] [PubMed] [Google Scholar]
  18. Leftwich J. A., Hall R. E. Purification and further characterization of a non-tumor necrosis factor alpha or beta differentiation-inducing cytokine, P48. Cancer Res. 1989 Aug 15;49(16):4459–4465. [PubMed] [Google Scholar]
  19. Lord K. A., Hoffman-Liebermann B., Liebermann D. A. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene. 1990 Jul;5(7):1095–1097. [PubMed] [Google Scholar]
  20. Melby P. C., Darnell B. J., Tryon V. V. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods. 1993 Feb 26;159(1-2):235–244. doi: 10.1016/0022-1759(93)90162-z. [DOI] [PubMed] [Google Scholar]
  21. Metcalf D. The colony stimulating factors. Discovery, development, and clinical applications. Cancer. 1990 May 15;65(10):2185–2195. doi: 10.1002/1097-0142(19900515)65:10<2185::aid-cncr2820651005>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  22. Metcalf D. The leukemia inhibitory factor (LIF). Int J Cell Cloning. 1991 Mar;9(2):95–108. doi: 10.1002/stem.5530090201. [DOI] [PubMed] [Google Scholar]
  23. Miyajima A., Miyatake S., Schreurs J., De Vries J., Arai N., Yokota T., Arai K. Coordinate regulation of immune and inflammatory responses by T cell-derived lymphokines. FASEB J. 1988 Jun;2(9):2462–2473. doi: 10.1096/fasebj.2.9.2836253. [DOI] [PubMed] [Google Scholar]
  24. Nakamura T., Kharbanda S., Spriggs D., Kufe D. Effects of dexamethasone on induction of monocytic differentiation in human U-937 cells by dimethylsulfoxide. J Cell Physiol. 1990 Feb;142(2):261–267. doi: 10.1002/jcp.1041420207. [DOI] [PubMed] [Google Scholar]
  25. Neta R., Sayers T. J., Oppenheim J. J. Relationship of TNF to interleukins. Immunol Ser. 1992;56:499–566. [PubMed] [Google Scholar]
  26. Orcel P., Bielakoff J., De Vernejoul M. C. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures. J Cell Physiol. 1990 Feb;142(2):293–298. doi: 10.1002/jcp.1041420211. [DOI] [PubMed] [Google Scholar]
  27. Pfefferkorn L. C., Guyre P. M., Fanger M. W. Functional comparison of the inductions of NADPH oxidase activity and Fc gamma RI in IFN gamma-treated U937 cells. Mol Immunol. 1990 Mar;27(3):263–272. doi: 10.1016/0161-5890(90)90139-q. [DOI] [PubMed] [Google Scholar]
  28. Tamatani T., Kimura S., Hashimoto T., Onozaki K. Purification of guinea pig tumor necrosis factor (TNF): comparison of its antiproliferative and differentiative activities for myeloid leukemic cell lines with those of recombinant human TNF. J Biochem. 1989 Jan;105(1):55–60. doi: 10.1093/oxfordjournals.jbchem.a122619. [DOI] [PubMed] [Google Scholar]
  29. Tracey K. J., Cerami A. Cachectin/tumor necrosis factor and other cytokines in infectious disease. Curr Opin Immunol. 1989 Feb;1(3):454–461. doi: 10.1016/0952-7915(88)90026-x. [DOI] [PubMed] [Google Scholar]
  30. Trechsel U., Evêquoz V., Fleisch H. Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J. 1985 Sep 1;230(2):339–344. doi: 10.1042/bj2300339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yamaguchi Y., Gunji Y., Nakamura M., Hayakawa K., Maeda M., Osawa H., Nagayoshi K., Kasahara T., Suda T. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp Hematol. 1993 Aug;21(9):1233–1238. [PubMed] [Google Scholar]
  32. van de Loosdrecht A. A., Beelen R. H., Ossenkoppele G. J., Broekhoven M. G., Langenhuijsen M. M. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha. Exp Hematol. 1993 Mar;21(3):461–468. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES